---
schema_version: 1
task_id: 20260910-engine-labs-company-os
role_id: product-manager-subagent
revision: 1
updated_at: 2026-09-10T16:00:00Z
---

# Role Evidence: product-manager-subagent

All records produced read-only on 2026-09-10 (UTC) in the local repository at `/Users/camdouglas/OrgOS`. No file was created or modified by this role. No secret values were read or recorded. Materialized by the orchestrating lead from the role's returned payload; lead verification notes are marked `[lead]`.

## Evidence record EV-01 — Required inputs present and read

- Requirement ID: charter §2, §11; plan §1
- Claim: Every required input existed and was read in full before analysis: `AGENTS.md`, `.cursor/AGENTS.md`, `.cursor/instructions/SUBAGENTS.md`, `.cursor/instructions/ROLES.md` §4 (`product-manager-subagent`), `.cursor/INSTRUCTIONS.md` registry, charter, plan, manifest, `docs/blueprints/2026-09-10_engine_labs.md`, `docs/plans/phase_0_foundations_plan.md`, `docs/blueprints/company_agent_system_blueprint.md` (414 lines), both templates.
- Evidence state: `VERIFIED`
- Method: Read tool on each path; `wc -l` and `ls` for the intake and workstream directory.
- Exact command or tool: Read; `wc -l docs/blueprints/company_agent_system_blueprint.md`; `ls docs/workstreams/20260910-engine-labs-company-os/product-manager-subagent`
- Artifact, path, source, or stable reference: paths above; `product-manager-subagent/` contained only `charter.md` and `plan.md` (no predecessor handoff, as declared).
- Sanitized result and exit status: 414 lines; exit 0.
- Timestamp: 2026-09-10T15:46Z
- Environment: read-only sandbox, macOS workstation
- Limitations: none
- Required follow-up: none

## Evidence record EV-02 — Intake coverage (every requirement-bearing section mapped)

- Requirement ID: REQ-02, REQ-05, REQ-06; charter §9
- Claim: All 18 intake phase headings (01–18) plus the two domain sub-headings are cited by at least one PRD/NFR/acceptance row; the traceability summary (`docs/product.md` §14) maps each heading to IDs.
- Evidence state: `VERIFIED`
- Method: Enumerated all headings with ripgrep; built citation key table I-01…I-18, I-02B, I-02P; cross-checked that each key appears in ≥1 requirement row.
- Exact command or tool: `rg -n "^#" docs/blueprints/company_agent_system_blueprint.md`
- Artifact, path, source, or stable reference: intake headings; `docs/product.md` §0.1, §14.
- Sanitized result and exit status: 21 headings found (1 title, 3 section headings, 18 phase headings — the `## First post-Build action` heading is protocol text, not a product requirement); exit 0.
- Timestamp: 2026-09-10T15:47Z
- Environment: as EV-01
- Limitations: Phase 01 is launch-protocol text owned by the lead (REQ-01). Sentence-level completeness was checked by reading, not by an automated diff.
- Required follow-up: PL gate (T0-12) may spot-check sentence-level mapping.

## Evidence record EV-03 — 43-domain bucket completeness

- Requirement ID: PRD-C.1; plan §6 task 4; charter §9
- Claim: All 24 business (B01–B24) and 19 platform (P01–P19) domain groups are listed by ID and intake name and assigned exactly one release bucket; totals R1 = 19, R2 = 4, R3 = 14, R4 = 6, sum 43.
- Evidence state: `VERIFIED`
- Method: Transcribed both intake tables row by row; counted rows in `docs/product.md` §4.3 (24) and §4.4 (19); summed bucket totals.
- Exact command or tool: Read of intake domain tables; manual count reproduced in `docs/product.md` §4.4 "Bucket totals".
- Artifact, path, source, or stable reference: `docs/product.md` §4.3, §4.4
- Sanitized result and exit status: 24 + 19 = 43; bucket sum 19 + 4 + 14 + 6 = 43.
- Timestamp: 2026-09-10T15:55Z
- Environment: as EV-01
- Limitations: R3/R4 split of business domains and the R2–R4 phase numbering are `proposal`; see EV-07.
- Required follow-up: `[lead]` row count verified after materialization (see handoff §6).

## Evidence record EV-04 — No prices, allowance quantities, or rates

- Requirement ID: PRD-G.10; charter §3 prohibited actions; charter §9
- Claim: `docs/product.md` contains no monetary amount, token quantity, seat count or rate for any tier; the intake itself contains no prices.
- Evidence state: `VERIFIED`
- Method: ripgrep of the intake for price/currency tokens; self-review of `docs/product.md` §8/§8.1.
- Exact command or tool: `rg -n -i "price|\$[0-9]" docs/blueprints/company_agent_system_blueprint.md`
- Artifact, path, source, or stable reference: intake "Price hosted capacity ... explicitly" and "Calculate prices ... before billing" (only matches); `docs/product.md` §8.1 columns are descriptive text only.
- Sanitized result and exit status: 2 matches, both non-numeric policy sentences; exit 0. Competitor price figures in blueprint §5 were deliberately not carried into `docs/product.md`.
- Timestamp: 2026-09-10T15:58Z
- Environment: as EV-01
- Limitations: Retention-day values (365/30/30) in PRD-F.4 are intake retention defaults, not prices.
- Required follow-up: none

## Evidence record EV-05 — Release-1 acceptance derivation ("Final result")

- Requirement ID: plan §6 task 6; charter §9
- Claim: The intake has no heading or phrase "Final result"; the release-1 acceptance definition (`docs/product.md` §9) is derived from the phase 06 table rows for 07 and 08, the phase 07/08 demonstration sentences, and the phase 13/18 registry and handoff rules.
- Evidence state: `PARTIAL` (derived, not quoted from a section of that name)
- Method: ripgrep for "Final result" across `docs/`; reading of intake phases 06–08, 13, 18.
- Exact command or tool: `rg -n "Final result" docs/`
- Artifact, path, source, or stable reference: matches only in `docs/plans/phase_0_foundations_plan.md` and the PM `plan.md`; none in the intake. `[lead]` independently confirmed with `rg -i "Final result|Tier 1|Tier 4"` on the intake (no "Final result"; tiers named Tier 1–4).
- Sanitized result and exit status: 2 matches outside the intake; exit 0.
- Timestamp: 2026-09-10T15:50Z
- Environment: as EV-01
- Limitations: If the owner holds a separate "Final result" text not in the repository, §9 must be reconciled against it.
- Required follow-up: Lead confirms the derivation is acceptable at T0-12 (assumption AS-9).

## Evidence record EV-06 — Acceptance criteria observability

- Requirement ID: charter §9; ROLES §4 gate
- Claim: Every PRD, NFR and R1-ACC row states an observable check rather than an intention; failure paths are covered by refusal/audit criteria (PRD-B.2, B.4, D.3, D.5, D.9–D.12, E.1, E.3, E.6, G.4) and edge cases by interruption/timeouts (PRD-E.7, E.8, B.7, R1-ACC-5).
- Evidence state: `VERIFIED`
- Method: Row-by-row self-review of `docs/product.md` tables.
- Exact command or tool: manual review
- Artifact, path, source, or stable reference: `docs/product.md` §1–§3, §5–§9, §11
- Sanitized result and exit status: 0 rows with a non-observable criterion after review.
- Timestamp: 2026-09-10T15:59Z
- Environment: as EV-01
- Limitations: Observability is asserted for the check type, not for the not-yet-existing implementation; numeric thresholds intentionally absent per I-06.
- Required follow-up: `software-engineer-subagent` confirms each check is implementable in `docs/verification.md`.

## Evidence record EV-07 — Release map consistency with the intake

- Requirement ID: REQ-06 inputs; plan §6 task 4
- Claim: R1 = phases 07 + 08 is verbatim from the intake (I-06). The intake assigns 09–12 only to "subsequent releases"; the blueprint fixes "releases 2–4". The mapping R2 = 09, R3 = 10, R4 = 11 + 12 is labelled `proposal` with the alternative recorded (OQ-3).
- Evidence state: `PARTIAL` (R1 verified; R2–R4 numbering proposal)
- Method: Reading intake phase 06; blueprint §4, §13; manifest §3.
- Exact command or tool: Read
- Artifact, path, source, or stable reference: `docs/product.md` §4.1, §12 OQ-3
- Sanitized result and exit status: consistent; no contradiction on R1.
- Timestamp: 2026-09-10T15:56Z
- Environment: as EV-01
- Limitations: as stated
- Required follow-up: owner decision OQ-3 before R2 closure

## Evidence record EV-08 — Registry schema column completeness

- Requirement ID: PRD-C.2; plan §6 task 3
- Claim: All ten column concepts named in the intake (user outcome; native or connector owner; read/write actions; data authority; required grants; dependencies; interface components; release phase; implementation status; acceptance evidence) appear in `docs/product.md` §3.1, plus the four status values.
- Evidence state: `VERIFIED`
- Method: Read of the intake sentence; column-by-column comparison.
- Exact command or tool: Read
- Artifact, path, source, or stable reference: `docs/product.md` §3.1, §3.2
- Sanitized result and exit status: 10/10 intake columns present (read/write split into two columns); 4/4 statuses present; additional columns marked `proposal`.
- Timestamp: 2026-09-10T15:54Z
- Environment: as EV-01
- Limitations: none
- Required follow-up: SE adopts schema in `docs/capabilities.md` (D-02).

## Evidence record EV-09 — Seat templates match the intake

- Requirement ID: PRD-D.1; plan §6 task 5
- Claim: Responsibilities and default authority in `docs/product.md` §5.1 are verbatim from the intake seat table; default views and prohibited exposures are derived (default views `proposal`; prohibited exposures from I-03).
- Evidence state: `VERIFIED`
- Method: Read and text comparison.
- Exact command or tool: Read
- Artifact, path, source, or stable reference: `docs/product.md` §5.1
- Sanitized result and exit status: 3/3 seats match.
- Timestamp: 2026-09-10T15:57Z
- Environment: as EV-01
- Limitations: none
- Required follow-up: none

## Evidence record EV-10 — No fabricated baselines, research, or metric values

- Requirement ID: ROLES §4; charter §6
- Claim: `docs/product.md` §10 records baseline = none and target = not set for every metric; no market, demand or performance figure is asserted. `.cursor/TOOLS.md` lists an analytics-warehouse tool that must be treated as unavailable until authenticated; no authentication was attempted.
- Evidence state: `VERIFIED`
- Method: ripgrep of `.cursor/TOOLS.md`; review of `docs/product.md` §10.
- Exact command or tool: `rg -n -i "analytics|bigquery|posthog|mixpanel" .cursor/TOOLS.md`
- Artifact, path, source, or stable reference: `.cursor/TOOLS.md` analytics entry; `docs/product.md` §10; blueprint §16.
- Sanitized result and exit status: tool present with "Treat ... as unavailable until authentication and dataset scope are verified"; exit 0.
- Timestamp: 2026-09-10T15:58Z
- Environment: as EV-01
- Limitations: none
- Required follow-up: Growth refines taxonomy at T0-10 without adding baselines.

## Evidence record EV-11 — Tier labels not in the intake

- Requirement ID: PRD-G.1; `docs/product.md` §8.1
- Claim: The intake names tiers "Tier 1"–"Tier 4". The labels Free/Basic/Professional/Enterprise appear only in the lead's delegation brief and are recorded as `proposal` (OQ-4).
- Evidence state: `VERIFIED` (as a labelling fact)
- Method: Read of the intake tier table.
- Exact command or tool: Read; `[lead]` `rg -i "Tier 1|Tier 4"` confirmed.
- Artifact, path, source, or stable reference: `docs/product.md` §8.1, §12 OQ-4
- Sanitized result and exit status: 0 occurrences of "Free", "Basic", "Professional", "Enterprise" as tier names in the intake.
- Timestamp: 2026-09-10T15:58Z
- Environment: as EV-01
- Limitations: none
- Required follow-up: owner decision OQ-4 before T0-10

## Evidence record EV-12 — Read-only compliance and no secrets

- Requirement ID: charter §3 (read-only); SUBAGENTS.md write ownership
- Claim: No write, edit, delete, MCP-write, or state-changing shell command was executed; only Read, Grep, and read-only shell (`wc`, `ls`, `rg`, `sed -n`, `date`) in a read-only sandbox. No secret values were read or reproduced.
- Evidence state: `VERIFIED`
- Method: Tool log of the role session.
- Exact command or tool: as listed in EV-01…EV-11
- Artifact, path, source, or stable reference: role session
- Sanitized result and exit status: all commands exit 0; sandbox reported "Filesystem: Read-only access".
- Timestamp: 2026-09-10T16:00Z
- Environment: as EV-01
- Limitations: none
- Required follow-up: Lead materialized `docs/product.md`, `evidence.md`, `handoff.md` on 2026-09-10.
